Ear nerve stimulation for fibromyalgia pain in Veterans
Tests a device that stimulates nerves in the ear in Veterans with fibromyalgia.
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Decatur, United StatesSee the site
- Trial code
- Registry title
- Auricular Neuromodulation in Veterans With Fibromyalgia
- Status
- Recruiting
- People taking part
- 240 people, planned
- Started
- 1 Nov 2024
- Expected to end
- 1 Nov 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Percutaneous electrical nerve field stimulation
- Record updated
- 22 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Veterans with fibromyalgia, a long-lasting pain condition. It tests an ear device that gives mild electrical stimulation against a fake (sham) device.
- Age
- 18 years or older. People who take part in the MRI scans must be 20-60 years old.
- Sex
- All sexes can join.
- Disease stage
- Fibromyalgia diagnosed by the American College of Rheumatology 2016 criteria. Pain score of 4 or greater on the DVPRS scale in the 3 months before joining.
Main reasons for not taking part
- Pregnancy (self-reported)
- History of seizures or brain-related nerve conditions
- Uncontrolled mental illness, or autoimmune disease that causes pain
- Skin problems that raise infection risk where the ear device goes, or broken skin there
- For the MRI part: fear of closed spaces, implants not safe in MRI, or not right-handed
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age 18 years or older; for those who participate in the MRI portion, age 20-60 years old (limit specifically set for participants receiving an MRI scan; limit set to minimize brain structural changes due to aging)
- For those who participate in the MRI portion, right-handedness, to provide consistency in brain structure and function (limit specifically set for participants receiving an MRI scan; limit set to minimize brain structural changes due to aging)
- For those who participate in the MRI portion, the ability to safely tolerate MRI
- Diagnosis of fibromyalgia by the American College of Rheumatology 2016 criteria69
- Pain score of 4 or greater on DVPRS51 in the 3 months prior to enrollment
- Intact skin in area of PENFS treatment
Who cannot take part
- History of seizures or neurologic conditions that alter the brain
- Claustrophobia, MRI-incompatible implants, or other conditions incompatible with MRI (only for those who participate in MRI)
- History of uncontrolled psychiatric illness, autoimmune disease that leads to pain, or skin conditions that can increase risk of infection at PENFS site
- Pregnancy (self-reported)
Where in United States
- Atlanta VA Medical and Rehab Center, Decatur, GADecatur, United StatesContact: Anna Woodbury, MDTaking people
About the trial
What the trial wants to find out
PENFS (percutaneous electrical nerve field stimulation) is an FDA-cleared acupuncture-like therapy applied to the external ear targeting several cranial nerve branches including the auricular branch of the vagus nerve to improve pain, physical function, and reduce symptoms of opioid withdrawal. PENFS has been previously shown to provide improvements in fibromyalgia, a difficult to treat chronic pain syndrome, which correlate with changes observed using a special kind of MRI called resting state functional connectivity MRI (rs-fcMRI) that evaluates brain activity at rest. The goals of this study are to rigorously test the initial promising results of PENFS in a much larger group of Veterans suffering from fibromyalgia and to identify potential mechanisms of PENFS effects. Further developing non-pharmacologic therapies for pain can help to improve quality of life and function for those suffering from fibromyalgia and decrease reliance on opioids and other drugs that have numerous side effects for individuals suffering from chronic pain.
The 2 groups in the trial
- True PENFSExisting treatment, for comparison
Percutaneous electrical nerve stimulation applied to the ear x 4 over a 4 week period. The device is placed over the area of the ear and worn home continuously for a 5-day period, during which time it stimulates at a pre-set on/off duty cycle. At each in-person visit, the device is replaced until the device has been placed 4 times. The stimulation delivered is below the threshold of sensory perception.
Treatment: Percutaneous electrical nerve field stimulation
- Sham PENFSSham treatment, for comparison
A device is placed at the same points for the same amount of time and at the same intervals as the true device. This device will not deliver electrical stimulation.
Treatment: Percutaneous electrical nerve field stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Auricular Neuromodulation in Veterans With Fibromyalgia: A Randomized, Sham-Controlled Study
- Plain-language title
- Ear nerve stimulation for fibromyalgia pain in VeteransGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Record updated
- 22 May 2026